Back to search
Oropharynx Cancer, Stage I
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Oropharynx Cancer, Stage I trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Oropharynx Cancer, Stage I trials you may qualify forThis phase II trial compares the effectiveness of adding BMX-001 to usual symptom management versus usual symptom management alone for reducing oral mucositis i…
The current standard treatment option for Human Papillomavirus (HPV) or p16-positive oropharyngeal cancer is full-dose radiation combined with chemotherapy. Res…
This trial uses blood tests and questionnaires to study how well participants with head and neck cancer that has spread to other places in the body adhere to sw…
This phase II trial studies how well using circulating tumor deoxyribonucleic acid (DNA) to guide lower dose radiation therapy works in treating patients with h…
The main goal of this phase of the study is to determine if objectively assessed Physical Activity (PA) levels in advanced-cancer patients are associated with h…
This study is a multicentric double-blind placebo-controlled dose escalation trial of a CD40HVac vaccine (humanized anti-CD40 mAb fused to HPV16 E6/E7 oncoprote…
This phase II/III trial studies how well a reduced dose of radiation therapy works with nivolumab compared to cisplatin in treating patients with human papillom…
This phase III trial compares cetuxumab to chemotherapy, carboplatin and paclitaxel, with intensity modulated radiation therapy for the treatment of patients wi…